# The Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2010

S.R. 2010/149 · made 12 April 2010 · revised to 28 March 2011

Section 7(3) of the Misuse of Drugs Act 1971 (“the 1971 Act”) requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under the 1971 Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting into Part 1 of the Schedule to that Order 4-Methylmethcathinone (commonly referred to as Mephedrone) and other cathinone derivatives.

Made under: Misuse of Drugs Act 1971 (Section 7)

PDFs: Printed copy https://openlegislation.uk/misuse-of-drugs-designation-amendment-order-northern-ireland-2010/pdf/nisr_20100149_en.pdf

## Introductory text

Dangerous Drugs
Made 12th April 2010
Coming into operation 16th April 2010
The Department of Health, Social Services and Public Safety makes the following Order in exercise of the powers conferred by sections 7(4) and (5) of the Misuse of Drugs Act 1971, as adapted by section 7(9) of the Act and now vested in it and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.

## 1 Citation and commencement

This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2010 and shall come into operation on 16th April 2010.

## 2 Interpretation

(1) In this Order “the 2001 Order” means the Misuse of Drugs (Designation) Order (Northern Ireland) 2001.
(2) The Interpretation Act (Northern Ireland) 1954 shall apply to this Order as it applies to an Act of the Assembly.

## 3 Amendments to the 2001 Order

In Part 1 of the Schedule to the 2001 Order—
(a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(c) after paragraph 1(p), insert—
“(q) Any compound (not being bupropion, diethylpropion, pyrovalerone or a compound for the time being specified in sub-paragraph (a) above) structurally derived from 2–amino-1-phenyl-1–propanone by modification in any of the following ways, that is to say,
(i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(ii) by substitution at the 3-position with an alkyl substituent;
(iii) by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.”.

## Signature

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 12th April 2010
(L.S.)
Norman Morrow
A senior officer of the Department of Health, Social Services and Public Safety

## Explanatory note

(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 (“the 1971 Act”) requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under the 1971 Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting into Part 1 of the Schedule to that Order 4-Methylmethcathinone (commonly referred to as Mephedrone) and other cathinone derivatives.

---
Source: https://www.legislation.gov.uk/nisr/2010/149 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-designation-amendment-order-northern-ireland-2010
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.